ALXO
ALX Oncology Holdings Inc
Price:  
1.42 
USD
Volume:  
2,638,565.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALXO WACC - Weighted Average Cost of Capital

The WACC of ALX Oncology Holdings Inc (ALXO) is 10.1%.

The Cost of Equity of ALX Oncology Holdings Inc (ALXO) is 10.85%.
The Cost of Debt of ALX Oncology Holdings Inc (ALXO) is 5.00%.

Range Selected
Cost of equity 9.50% - 12.20% 10.85%
Tax rate -% - 0.10% 0.05%
Cost of debt 5.00% - 5.00% 5.00%
WACC 9.0% - 11.3% 10.1%
WACC

ALXO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.23 1.3
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.50% 12.20%
Tax rate -% 0.10%
Debt/Equity ratio 0.14 0.14
Cost of debt 5.00% 5.00%
After-tax WACC 9.0% 11.3%
Selected WACC 10.1%